Which has grown faster, ADUS or BCRX?

Over the past five years, BCRX grew revenue faster — ADUS at a 12.67% CAGR versus BCRX at 64.07%.

Is ADUS or BCRX more profitable?

ADUS runs the higher net margin — ADUS at 7.13% versus BCRX at -40.90%.

How have ADUS and BCRX total returns compared?

Over the past 10 years, ADUS delivered 15.62% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Addus HomeCare Corporation (ADUS) vs BioCryst Pharmaceuticals, Inc. (BCRX)

A side-by-side comparison of Addus HomeCare Corporation and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADUS

Addus HomeCare Corporation

$2.11B

$113.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

BCRX

BioCryst Pharmaceuticals, Inc.

$2.02B

$7.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADUS vs BCRX

growth of $100 · dividends reinvested · last 10y

ADUS +316.7% (+15.3%/yr)BCRX +78.8% (+6.0%/yr)ADUS compounded faster over this window

ADUS BCRX

ADUS vs BCRX: by the numbers

•ADUS is the larger company ($2.11B vs $2.02B market cap).
•ADUS is profitable (7.13% net margin) while BCRX runs a net loss (-40.90%).
•BCRX grew revenue faster over the past five years (64.07% vs 12.67% CAGR).

Metrics side by side

Valuation

Metric	ADUS	BCRX
P/E ratio	19.85	N/A
Forward P/E	16.06	N/A
PEG ratio	0.98	N/A
P/S ratio	1.43	2.15
P/B ratio	1.84	N/A
EV / EBITDA	12.86	N/A
FCF yield	7.25%	17.67%

Profitability

Metric	ADUS	BCRX
Gross margin	32.36%	97.82%
Operating margin	10.04%	38.98%
Net margin	7.13%	-40.90%
ROE	9.17%	N/A
ROIC	8.61%	-89.73%

Growth (annualized)

Metric	ADUS	BCRX
Revenue CAGR (5Y)	12.67%	64.07%
EPS CAGR (5Y)	19.61%	N/A
FCF CAGR (5Y)	24.41%	N/A
Total return CAGR (5Y)	8.33%	-10.02%

Frequently asked

Which has grown faster, ADUS or BCRX?: Over the past five years, BCRX grew revenue faster — ADUS at a 12.67% CAGR versus BCRX at 64.07%.
Is ADUS or BCRX more profitable?: ADUS runs the higher net margin — ADUS at 7.13% versus BCRX at -40.90%.
How have ADUS and BCRX total returns compared?: Over the past 10 years, ADUS delivered 15.62% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysis Full BCRX analysis Interactive comparison tool

Dig into the metrics

Addus HomeCare P/E ratio Addus HomeCare ROE BioCryst Pharmaceuticals ROE Addus HomeCare operating margin BioCryst Pharmaceuticals operating margin Addus HomeCare revenue growth BioCryst Pharmaceuticals revenue growth Addus HomeCare free cash flow BioCryst Pharmaceuticals free cash flow

Addus HomeCare & BioCryst Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.